bpc 157 heart failure BPC-157 continues to be one of the most talked-about peptides BPC-157 – Mark Hyman, MD

GHRP-6 Hexapeptide ghrelin mimetic - studied for GH release and food-intake research

The research-peptide market is unregulated, and third-party testing consistently finds products that don't match their labels

So, is one superior to the other

What distinguishes BPC-157 from other regenerative peptides is its broad spectrum of proposed effects

Nevertheless, multiple clinical trials testing different cyclic dinucleotides [e.g., BMS-986301 (NCT03956680) or BI 1387446 (NCT04147234)] either alone or in combination with other cancer therapies are currently ongoing and will ultimately determine the future relevance of STING agonists in a clinical setting (www.clinicaltrials.gov)